Decision-making for generic drug entry and branded drug lifecycle management
Want insights into the biggest revenue-changing events?
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
✓ When will key drug patents expire?
✓ How can I write stronger patents?
✓ How can I defeat drug patents?
✓ How can I find, evaluate, and plan for generic market entry opportunities?
✓ How can I find proprietary out-of-court settlements and deal terms?
Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children
Unknown status
Canadian Institutes of Health Research (CIHR)
Phase 3
2003-06-01
The purpose of this study is to determine whether semi-annual fluoride varnish applications
combined with caregiver counseling are effective in preventing and reducing a severe form of
dental decay, known as early childhood caries, in native and non-native children aged 6
months to 5 years.
Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children
Unknown status
The Hospital for Sick Children
Phase 3
2003-06-01
The purpose of this study is to determine whether semi-annual fluoride varnish applications
combined with caregiver counseling are effective in preventing and reducing a severe form of
dental decay, known as early childhood caries, in native and non-native children aged 6
months to 5 years.
Fluoride Varnish in the Prevention of Dental Caries in Aboriginal and Non-aboriginal Children
Unknown status
University of Toronto
Phase 3
2003-06-01
The purpose of this study is to determine whether semi-annual fluoride varnish applications
combined with caregiver counseling are effective in preventing and reducing a severe form of
dental decay, known as early childhood caries, in native and non-native children aged 6
months to 5 years.
Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate
Withdrawn
Ortho-McNeil Janssen Scientific Affairs, LLC
Phase 4
2010-04-01
The purpose of the proposed study is to determine the effectiveness of methylphenidate HCl
(Concerta) in college students with ADHD. This study will consist of 110 college students
between the ages of 18 and 25 who are enrolled full-time in a local or junior college. The
study consists of an 8-week double-blind, placebo-controlled trial of placebo versus
methylphenidate HCl (Concerta®) followed by a 10-week extension of open label
methylphenidate HCl (Concerta®).
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
